Opening Times | Register | Contact Us
CQC Rating Good
Clinical trial testing a new treatment for blood lowering drugs
New clinical trial called GMRx2 (George Medicines Research Study), single pill containing three widely used blood lowering drugs.
This is a clinical trial testing a new treatment called GMRX2, which is a single pill containing three widely used blood lowering drugs- Telmisartan, Amlodipine and Indapamide.
The purpose of this trial is to find out if the GMRx2 triple combination medication is equally or more effective and as safe in lowering high blood pressure compared with any combination of 2 active ingredients. We also want to find out GMRx2 is effective at controlling high blood pressure without increasing side effects.
This is a global study that enrol up to 1500 participants across the USA, UK, Australia, New Zealand, Czech Republic, Poland and Sri Lanka.
Who can take part
Adults aged 18 or older who are taking 3 or fewer blood pressure lowering drugs for their high blood pressure.
If you decide to take part , you will be asked to attend clinic for a minimum of 4 and up to 6 visits, with each visit lasting about 2 hours. The total duration of you participation will be approximately 20 weeks. Your first visit is called a screening visit and at this visit your trial doctor will check that you are eligible to in the study.
Published: Sep 21, 2022
We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.